Trinder, Matthew W <br/><br/>
Efficacy of adalimumab for the management of inflammatory bowel disease in the clinical setting.  [electronic resource] 

 -  Journal of gastroenterology and hepatology  Jul 2009 
 - 1252-7 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1440-1746 
<br/><br/><label>Standard No.: </label>10.1111/j.1440-1746.2009.05786.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adalimumab<br/>Adolescent<br/>Adult<br/>Anti-Inflammatory Agents--administration & dosage<br/>Antibodies, Monoclonal--administration & dosage<br/>Antibodies, Monoclonal, Humanized<br/>Australia<br/>Child<br/>Colitis, Ulcerative--diagnosis<br/>Crohn Disease--diagnosis<br/>Drug Administration Schedule<br/>Female<br/>Gastrointestinal Agents--administration & dosage<br/>Humans<br/>Infliximab<br/>Male<br/>Middle Aged<br/>Prospective Studies<br/>Remission Induction<br/>Severity of Illness Index<br/>Time Factors<br/>Treatment Failure<br/>Tumor Necrosis Factor-alpha--antagonists & inhibitors<br/>Young Adult